Proof Of Concept: How A Charity Bridges Lab And Clinic

Cancer Research UK is best known for funding science. But its commercial arm, Cancer Research Horizons, does something less obvious: it builds companies. This episode features Phil Masterson and Neil Jones, who run its ventures and drug discovery arms, unpacking why charities are increasingly bridging the gap between a promising result in the lab and a medicine in the clinic. Drug discovery, oncology, cancer research, R&D, venture capital, early-stage investment